Nektar Therapeutics | NKTR - Market Capitalization


Nektar Therapeutics reported $7.05B in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
ALKERMES USD 8.73B 2.85B Jun/2026
Alterity Therapeutics Limited AUD 39M 17M Sep/2026
Amgen USD 195.44B 5.55B Jun/2026
Baxter International USD 11.01B 2.34B Jun/2026
BioCryst Pharmaceuticals USD 2.54B 880M Jun/2026
Biogen USD 31.9B 5B Jun/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Cara Therapeutics USD 30M 336M Mar/2026
Cipla INR 1.18T 194.93B Jun/2026
Dr.Reddys Laboratories INR 1.13T 85.62B Jun/2026
Eisai JPY 1.2T 219.32B Jun/2026
Eli Lilly USD 1.13T 260.54B Jun/2026
Exelixis USD 13.54B 2.65B Jun/2026
Gilead Sciences USD 156.86B 16.13B Jun/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Halozyme Therapeutics USD 9.28B 1.63B Jun/2026
Incyte USD 22.65B 3.92B Jun/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
Karyopharm Therapeutics USD 126M 9M Mar/2026
MacroGenics USD 184M 82M Mar/2026
Merck USD 317.37B 20.27B Jun/2026
Nektar Therapeutics USD 2.12B 1.26B Mar/2026
Neurocrine Biosciences USD 16.95B 3.7B Jun/2026
Novartis USD 240.59B 67.17B Jun/2026
Pfizer USD 138.44B 15.37B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sarepta Therapeutics USD 1.9B 388M Jun/2026
Takeda JPY 8.2T 809.7B Jun/2026
Teva Pharmaceutical Industries USD 114.54B 80.27B Jun/2026
Xencor USD 1.19B 301M Jun/2026